Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05696236 · ClinicalTrials.gov registry record · NA
Predicting Peanut Anaphylaxis and Reducing Epinephrine
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT05696236 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 51 participants.
The verdict
NCT05696236, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
This research study is testing a new way to look for the early stages of anaphylaxis. Eligible participants will have a small monitor (transepidermal water loss) placed on the forearm during a food challenge (for peanut allergies). This monitor continuously records the amount of water lost through the skin. In a previous study the team learned what values are associated with an anaphylactic reaction. These values are called "stopping rules." This study is looking at whether it can use these new stopping rules to end the oral food challenge before a person may show any symptoms.
Interventions
- DEVICE Transepidermal water loss (TEWL) monitor and stopping rules
- DEVICE Monitor (TEWL) without stopping rules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05696236
The ClinicalTrials.gov registry entry for NCT05696236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transepidermal water loss (TEWL) monitor and stopping rules is the first listed.
NCT05696236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05696236 about?
NCT05696236 is a clinical study titled "Predicting Peanut Anaphylaxis and Reducing Epinephrine". This research study is testing a new way to look for the early stages of anaphylaxis. Eligible participants will have a small monitor (transepidermal water loss) placed on the forearm during a food challenge (for peanut allergies). This monitor continuously records the amount of water lost through t...
What is the current status of trial NCT05696236?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2023-05-23. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT05696236?
The interventions under investigation include: Transepidermal water loss (TEWL) monitor and stopping rules (DEVICE), Monitor (TEWL) without stopping rules (DEVICE).
Who is sponsoring clinical trial NCT05696236?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.